Found 0 matching trials
Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS PHASE1 Prospective, single center, open label, phase I/IIa escalating dose study. ...
Show More Location
Tel Aviv Medical Center
Learn More & Join Trial
Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis N/A The aim of this research is to understand how lipids such as cholesterol af...
Show More Location
University College London Hospitals NHS Foundation Trust
Learn More & Join Trial
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases PHASE1 The specific aims of the study are:
Primary: To determine the presence and...
Show More Location
Brigham MS Center, 60 Fenwood Road
Learn More & Join Trial
BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis PHASE3 The primary objective of the study is to investigate whether treatment with...
Show More Learn More & Join Trial
PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF PHASE1 This is a study of PIPE-791, an investigational study drug to treat progres...
Show More Location
Hammersmith Medicines Research
Learn More & Join Trial
Measuring Active Microglia in Progressive Multiple Sclerosis N/A This is pilot study designed to quantifying the innate immune inflammatory ...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis PHASE2 The purpose of this study is to determine whether MIS416 administered once ...
Show More Location
The Wesley-St. Andrew's Research Institute
Learn More & Join Trial
Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition PHASE2 Approximately 50% of people diagnosed with Multiple Sclerosis (MS) will dev...
Show More Location
University of California Los Angeles
Learn More & Join Trial
Outpatient Hematopoietic Grafting in Multiple Sclerosis Employing Autologous Peripheral Blood Stem Cells NA Multiple sclerosis (MS) is a chronic, inflammatory, debilitating disease th...
Show More Location
Multiple Locations
Learn More & Join Trial
Dose Escalation Study to Evaluate the Penetration and Pharmacodynamic Effects of Baminercept in the Cerebrospinal Fluid (CSF)and Safety in Subjects With Secondary Progressive Multiple Sclerosis (SPMS) PHASE1 This is a prospective, randomized, multicenter, dose escalation study to de...
Show More Location
Multiple Locations
Learn More & Join Trial